151 related articles for article (PubMed ID: 9873502)
1. Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3.
Fujishima T; Liu Z; Miura D; Chokki M; Ishizuka S; Konno K; Takayama H
Bioorg Med Chem Lett; 1998 Aug; 8(16):2145-8. PubMed ID: 9873502
[TBL] [Abstract][Full Text] [Related]
2. Design and efficient synthesis of 2 alpha-(omega-hydroxyalkoxy)-1 alpha,25-dihydroxyvitamin D3 Analogues, including 2-epi-ED-71 and their 20-epimers with HL-60 cell differentiation activity.
Saito N; Suhara Y; Kurihara M; Fujishima T; Honzawa S; Takayanagi H; Kozono T; Matsumoto M; Ohmori M; Miyata N; Takayama H; Kittaka A
J Org Chem; 2004 Oct; 69(22):7463-71. PubMed ID: 15497970
[TBL] [Abstract][Full Text] [Related]
3. Highly potent cell differentiation-inducing analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological activity of 2-methyl-1,25-dihydroxyvitamin D3 with side-chain modifications.
Fujishima T; Zhaopeng L; Konno K; Nakagawa K; Okano T; Yamaguchi K; Takayama H
Bioorg Med Chem; 2001 Feb; 9(2):525-35. PubMed ID: 11249144
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20.
Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Yamaguchi K; Kan Y; Kurihara M; Miyata N; Smith C; DeLuca HF; Takayama H
J Med Chem; 2000 Nov; 43(22):4247-65. PubMed ID: 11063621
[TBL] [Abstract][Full Text] [Related]
5. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells.
Nakagawa K; Kurobe M; Ozono K; Konno K; Fujishima T; Takayama H; Okano T
Biochem Pharmacol; 2000 Mar; 59(6):691-702. PubMed ID: 10677586
[TBL] [Abstract][Full Text] [Related]
6. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and testing of 2alpha-modified 1alpha,25-dihydroxyvitamin D(3) analogues with a double side chain: marked cell differentiation activity.
Suhara Y; Kittaka A; Kishimoto S; Calverley MJ; Fujishima T; Saito N; Sugiura T; Waku K; Takayama H
Bioorg Med Chem Lett; 2002 Nov; 12(22):3255-8. PubMed ID: 12392726
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of A-ring diastereomers of 1alpha,25-dihydroxy-22-oxavitamin D3 (OCT).
Hatakeyama S; Okano T; Maeyama J; Esumi T; Hiyamizu H; Iwabuchi Y; Nakagawa K; Ozono K; Kawase A; Kubodera N
Bioorg Med Chem; 2001 Feb; 9(2):403-15. PubMed ID: 11249133
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of 22-iodo- and (E)-20(22)-dehydro analogues of 1alpha,25-dihydroxyvitamin D3.
Sicinski RR; DeLuca HF
Bioorg Med Chem; 1999 Dec; 7(12):2877-89. PubMed ID: 10658592
[TBL] [Abstract][Full Text] [Related]
10. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
Yamamoto K; Inaba Y; Yoshimoto N; Choi M; DeLuca HF; Yamada S
J Med Chem; 2007 Mar; 50(5):932-9. PubMed ID: 17298045
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and biological evaluation of novel 2alpha-substituted 1alpha,25-dihydroxyvitamin D3 analogues.
Suhara Y; Nihei KI; Tanigawa H; Fujishima T; Konno K; Nakagawa K; Okano T; Takayama H
Bioorg Med Chem Lett; 2000 May; 10(10):1129-32. PubMed ID: 10843234
[TBL] [Abstract][Full Text] [Related]
12. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
Sicinski RR; Prahl JM; Smith CM; DeLuca HF
J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
[TBL] [Abstract][Full Text] [Related]
13. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological studies of the A-ring-modified 1,25-dihydroxyvitamin D3 analogs.
Takayama H; Kittaka A; Fujishima T; Suhara Y
Recent Results Cancer Res; 2003; 164():289-317. PubMed ID: 12899530
[TBL] [Abstract][Full Text] [Related]
15. Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3).
Takayama H; Konno K; Fujishima T; Maki S; Liu Z; Miura D; Chokki M; Ishizuka S; Smith C; DeLuca HF; Nakagawa K; Kurobe M; Okano T
Steroids; 2001; 66(3-5):277-85. PubMed ID: 11179735
[TBL] [Abstract][Full Text] [Related]
16. Concise synthesis and biological activities of 2alpha-alkyl- and 2alpha-(omega-hydroxyalkyl)-20-epi-1alpha,25-dihydroxyvitamin D3.
Honzawa S; Suhara Y; Nihei K; Saito N; Kishimoto S; Fujishima T; Kurihara M; Sugiura T; Waku K; Takayama H; Kittaka A
Bioorg Med Chem Lett; 2003 Oct; 13(20):3503-6. PubMed ID: 14505658
[TBL] [Abstract][Full Text] [Related]
17. Remarkable effect of 2[small alpha]-modification on the VDR antagonistic activity of 1small alpha-hydroxyvitamin D3-26,23-lactones.
Saito N; Matsunaga T; Fujishima T; Anzai M; Saito H; Takenouchi K; Miura D; Ishizuka S; Takayama H; Kittaka A
Org Biomol Chem; 2003 Dec; 1(24):4396-402. PubMed ID: 14685312
[TBL] [Abstract][Full Text] [Related]
18. A novel and practical route to A-ring enyne synthon for 1 alpha,25-dihydroxyvitamin D3 analogs: synthesis of A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D2 and 3-methyl-1,25-dihydroxyvitamin D3.
Konno K; Maki S; Fujishima T; Liu Z; Miura D; Chokki M; Takayama H
Bioorg Med Chem Lett; 1998 Jan; 8(2):151-6. PubMed ID: 9871644
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
[TBL] [Abstract][Full Text] [Related]
20. A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1α,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo.
Flores A; Massarelli I; Thoden JB; Plum LA; DeLuca HF
J Med Chem; 2015 Dec; 58(24):9731-41. PubMed ID: 26630444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
